Shaanxi, China

Ruixin Li

This inventor holds 1 USPTO granted patent. Top assignee: Xi'an Jiaotong University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruixin Li. Retrieved from https://idiyas.com/inventor/ruixin-li-prgcrsvd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ruixin Li in Histotripsy Technology

Introduction

Ruixin Li is a notable inventor based in Shaanxi, China. He has made significant contributions to the field of medical technology, particularly in the area of histotripsy. His innovative methods aim to enhance the precision and effectiveness of ultrasound treatments.

Latest Patents

Ruixin Li holds a patent for a method titled "Method for controlling histotripsy using confocal fundamental and harmonic superposition combined with hundred-microsecond ultrasound pulses." This patent outlines a comprehensive approach to controlling histotripsy, which includes several key stages. The first stage involves positioning target tissue using a monitoring and guiding system, followed by the formation of a shock wave in a focal zone. The second stage focuses on further mechanical disintegration and homogenization of the target tissue through pulsed-ultrasound sequences.

Career Highlights

Ruixin Li is affiliated with Xi'an Jiaotong University, where he continues to advance his research and development in ultrasound technology. His work has garnered attention for its potential applications in non-invasive medical treatments.

Collaborations

Ruixin Li collaborates with esteemed colleagues, including Mingzhu Lu and Yizhe Geng, who contribute to his research endeavors. Their combined expertise enhances the innovative approaches being developed in histotripsy.

Conclusion

Ruixin Li's contributions to histotripsy technology exemplify the intersection of innovation and medical science. His patented methods represent a significant advancement in non-invasive treatment options, showcasing the potential for improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…